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Abstract: Renal tubular acidosis (RTA) is characterized by metabolic acidosis due to renal impaired acid excretion. Hy-
perchloremic acidosis with normal anion gap and normal or minimally affected glomerular filtration rate defines this dis-
order. RTA can also present with hypokalemia, medullary nephrocalcinosis and nephrolitiasis, as well as growth retarda-
tion and rickets in children, or short stature and osteomalacia in adults. In the past decade, remarkable progress has been 
made in our understanding of the molecular pathogenesis of RTA and the fundamental molecular physiology of renal tu-
bular transport processes. This review summarizes hereditary diseases caused by mutations in genes encoding transporter 
or channel proteins operating along the renal tubule. Review of the molecular basis of hereditary tubulopathies reveals 
various loss-of-function or gain-of-function mutations in genes encoding cotransporter, exchanger, or channel proteins, 
which are located in the luminal, basolateral, or endosomal membranes of the tubular cell or in paracellular tight junc-
tions. These gene mutations result in a variety of functional defects in transporter/channel proteins, including decreased 
activity, impaired gating, defective trafficking, impaired endocytosis and degradation, or defective assembly of channel 
subunits. Further molecular studies of inherited tubular transport disorders may shed more light on the molecular patho-
physiology of these diseases and may significantly improve our understanding of the mechanisms underlying renal salt 
homeostasis, urinary mineral excretion, and blood pressure regulation in health and disease. The identification of the mo-
lecular defects in inherited tubulopathies may provide a basis for future design of targeted therapeutic interventions and, 
possibly, strategies for gene therapy of these complex disorders. 
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INTRODUCTION 
  The term Renal Tubular Acidosis (RTA) defines many 
disorders characterized by metabolic acidosis, secondary to 
defects in renal tubular reabsorption of bicarbonate (HCO3
) 
and/or in urinary excretion of hydrogen (H
+), while glomeru-
lar function is little or not affected [1-6]. All forms of RTA 
present hyperchloremic metabolic acidosis, with normal an-
ion gap and are chronic diseases with significant impact on 
the quality of life of affected patients when left untreated, 
possibly leading to growth failure, osteoporosis, rickets, 
nephrolithiasis and even renal insufficiency [1-6].  
  Defects in proximal bicarbonate reclamation or distal 
acid secretion give rise to the respective clinical syndromes 
of proximal or distal RTA [1-6]. These disorders can be pri-
mary, originating from genetic defects on tubular transport 
mechanisms [7], or secondary to systemic diseases and to 
adverse drug reactions [8-12]. The familial conditions ex-
hibit distinct inheritance patterns. Distal RTA can be trans-
mitted as either an autosomal dominant or an autosomal re-
cessive trait, whereas isolated proximal RTA usually occurs 
as an autosomal recessive disease [6,7,13]. In the past few 
years, the molecular genetic strategies of positional cloning 
and candidate gene analysis have been combined to identify  
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the genes responsible for these inherited conditions [6,13]. 
This review will summarize the mechanisms of acid-base 
regulation by the kidney and the current understanding of the 
genetic causes of primary inherited RTA. It will, in addition, 
evaluate the ability of known functional and biochemical 
properties of these mutant proteins to explain the patho-
physiology of associated renal acidification defects. 
BRIEF OVERVIEW OF RENAL ACID-BASE HO-
MEOSTASIS 
  The kidney plays two major roles in acid-base homeosta-
sis. First, the filtered bicarbonate load (approximately 4000 
mmol/day) must be reabsorbed, mainly in the proximal tu-
bule and beyond in the loop of Henle and distal nephron. 
This reclamation process in the proximal tubule minimally 
requires the following: hydrogen (H
+) secretion of an equiva-
lent amount via the luminal Na
+/H
+ exchanger (NHE-3) and 
the vacuolar H
+-ATPase; luminal carbonic anhydrase type 
IV (CAIV) and cytosolic carbonic anhydrase type II (CAII); 
and basolateral bicarbonate exit through the electrogenic 
Na
+-dependent bicarbonate cotransporter (NBC-1) [2,14-17]. 
Second, the kidney must regenerate new bicarbonate (ap-
proximately 50 ± 100 mmol/ day) in the process of acid-
secretion, mainly in the collecting ducts, to match the 
amount of newly produced acid load by systemic metabolism 
[18,19]. In addition to sufficient buffer in the lumen, this 
process requires activities of several transport proteins of the 
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vacuolar H
+-ATPase, CA II, and the basolateral chloride-
bicarbonate exchanger, AE1 [18,20,21]. 
Proximal Tubular Bicarbonate Reabsorption 
 HCO3
- is freely filtered at the glomerulus and approxi-
mately 80 to 90% of this is reabsorbed in the proximal tubule 
[6]. In the tubular lumen, HCO3
- combines with H
+ in a reac-
tion catalyzed by CA IV, which is bound to the luminal 
membrane of proximal tubular cells [2,14,15]. This reaction 
produces carbonic acid, which is promptly converted to CO2 
and H2O. The resulting CO2 rapidly diffuses into the tubular 
cells and is combined with water to produce intracellular H
+ 
and HCO3
-. This intracellular reaction is catalyzed by CA II. 
HCO3
- is then cotransported with Na
+ into blood (with a 
probable stoichiometry of 3 HCO3
– to 1 Na
+) [6] via  the 
NBC-1, located on the basolateral cell membrane. The intra-
cellular H
+ produced by CA II is secreted into the tubular 
lumen predominantly via the NHE-3, situated on the luminal 
membrane [6,15,22]. This transport process is called facili-
tated diffusion and depends on the sodium concentration 
gradient generated by the action of a basolateral membrane 
Na
+-K
+-ATPase. It should be mentioned that there is mini-
mal net acid excretion in the proximal tubule, since most of 
the H
+ secretion is coupled with HCO3
- reabsorption [6,13]. 
The small amount of remaining H
+ will be buffered by phos-
phate as titratable acid. HCO3
- reabsorption is influenced by 
luminal HCO3
- concentration and pH, luminal flow rate, 
peritubular pCO2, and angiotensin II [2,6,17]. 
  Proximal tubular cells are capable of generating “extra” 
bicarbonate through the deamination of glutamine to gluta-
mate, then forming -ketoglutarate and eventually glucose. 
This metabolic process produces HCO3
- and NH4
+: the for-
mer reclaimed via the basolateral membrane and the latter 
secreted into the tubular lumen. This pathway can be upregu-
lated in states of chronic acidosis [3,6,15]. 
  The main mechanisms of proximal tubular bicarbonate 
reabsorption are displayed in Fig. (1). 
Distal Tubular Hydrogen Secretion 
  One of the important roles of the collecting duct segment 
of the nephron is acid secretion, combined with reclamation 
of the approximately 10% of filtered HCO3
- that is not reab-
sorbed by more proximal nephron segments [18]. The aver-
age omnivorous human diet in the `Western' world is rich in 
protein, and generates 1±1.5 mmol hydrogen/kg body weight 
each day [23]. Urinary acid excretion is therefore essential, 
and urine pH can drop as low as 4.5. The -intercalated cell 
is the main responsible for hydrogen secretion into the urine. 
In humans at least, hydrogen pumps, called H
+-ATPases, 
mainly carry out hydrogen secretion [18,19,23]. H
+-ATPases 
are present at high density on the luminal membrane of -
intercalated cells [18]. Studies in nonhuman mammals show 
that these H
+-ATPases are also present within specialized 
intracellular tubulovesicles close to the membrane, allowing 
additional pumps to be recruited to the membrane quickly in 
to response to stimuli, such as systemic acidosis, for example 
[23]. These cells secrete H
+ into the lumen of the distal tu-
bule and collecting duct not only via H+-ATPase but possi-
bly also by an exchanger, H
+/K
+-ATPase [7,10]. In addition, 
the normal function of the luminal H
+-ATPase in -
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic model of bicarbonate (HCO3
-) proximal reabsorption. The intracellular carbonic acid (H2CO3
-) dissociates into H
+ and 
HCO3
- in a reaction catalysed by a cytoplasmic carbonic anhydrase (CAII). At the luminal membrane, H
+ secretion is due to an especific Na
+ 
– H
+ exchanger (NHE-3), while, at the basolateral membrane, the 1 Na
+ - 3 HCO3
- cotransporter (NBC-1) is responsible for HCO3
- transport 
to the peritubular capilar. The secreted H
+ reacts with filtered HCO3
- to form luminal H2CO3, which is dissociated into H2O and CO2 by the 
action of membrane-bound carbonic anhydrase (CAIV). The generated CO2 diffuses back into the cell to complete the HCO3
- reabsorption 
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intercalated cells is coupled, in a poorly understood manner, 
to the electroneutral transport of HCO3
- back across the baso-
lateral surface into the interstitial fluid, and hence to blood. 
The transporter responsible for this activity in renal -
intercalated cells is the Cl
-/HCO3
- exchanger AE1 [7,20,21]. 
The AE1 exchanger is homologous with the red cell anion 
exchanger known as ‘band 3’ (eAE1) [6,24]. After the red 
cell, the kidney is the next richest source of this protein 
(kAE1) [24]. Proton secretion varies with systemic pH and it 
is also aldosterone-dependent and voltage-dependent [24]. 
  Once secreted, net urinary elimination of H
+ depends on 
its buffering and excretion as titratable acid (mainly phos-
phate - HPO4
2 + H
+  H2PO4
), and excretion as NH4
+ [24]. 
Notably, the production of NH4
+ from glutamine by the 
proximal tubule, and its subsequent excretion in the urine, 
also generates ‘new’ bicarbonate, which is added to plasma 
[24]. Availability of phosphate as a buffer depends on its 
filtration, whereas NH4
+ depends on normal function of the 
proximal tubule, as well as a complex process of secretion, 
reabsorption, and secretion again along the nephron [24]. 
The final secretory step for NH4
+ excretion is ‘diffusion 
trapping’ in the collecting duct. Anything that interferes with 
H
+ secretion in the collecting duct will reduce diffusion trap-
ping and cause a decrease in excretion of both H
+ and NH4
+ 
[6,24]. As previously mentioned, chronic metabolic acidosis 
stimulates renal NH4
+ synthesis and excretion [3,6,15]. 
 Fig. (2) shows renal acidification process in -intercalated 
cells of the distal nephron. 
CLASSIFICATION AND CLINICAL FEATURES OF 
RENAL TUBULAR ACIDOSIS 
  Clinically, RTA is characterized by a normal anion gap, 
hyperchloremic metabolic acidosis, and associated failure to 
thrive secondary to growth failure as well as anorexia [13]. 
Polyuria and constipation can also be seen, although neither 
may be apparent in the neonatal period [13]. Hyperchloremic 
metabolic acidosis in pediatric practice is most often associ-
ated with diarrheal disease. Both diarrhea and RTA result in 
hypokalemia. For this reason, in a young infant with diarrhea 
and underlying RTA, the true diagnosis may be obscured. 
Thus, inordinately slow resolution of hyperchloremic meta-
bolic acidosis following diarrheal disease should suggest the 
possibility of an underlying primary RTA [13]. 
  Beyond the difficulties inherent in delineating RTA, 
RTA can be subcategorized into different disorders with dis-
tinctly diverse prognoses [13]. The diagnostic cataloguing of 
RTA is based on the underlying pathophysiology. The cur-
rent model of how the nephron reabsorbs HCO3
 and secretes 
H
+ has led to a clinical and functional classification of 
proximal (tubule) versus distal (tubule and collecting duct) 
forms of RTA [24]. Thus, the main types of RTA are proxi-
mal (or type 2) RTA and distal (or type 1) RTA. Type 3 
RTA is a mixed type RTA that exhibits both impaired 
proximal HCO3
– reabsorption and impaired distal acidifica-
tion, and more disturbingly osteopetrosis, cerebral calcifica-
tion and mental retardation [4]. Hyperkalemic (or type 4) 
RTA is a heterogeneous group of disorders that is character-
ized by low urine NH4
+, which is probably caused by the 
hyperkalemia or by aldosterone deficiency or defective sig-
naling [4]. 
  In distal RTA, distal nephron net acid secretion is im-
paired. This leads to a high urine pH, even in the presence of 
systemic acidosis [2,4]. However, there is often no metabolic 
acidosis and the blood bicarbonate concentration is normal, 
so-called ‘incomplete’ distal RTA, and a defect in renal acid 
excretion must be demonstrated by a failure to lower urine 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Schematic model of the -intercalated cell and the H
+ secretion in cortical collecting tubule. The -intercalated cell is responsible 
for H
+ secretion by a vacuolar H
+-ATPase (main pump) and also by a H
+-K
+-ATPase. The luminal ammonia (NH3) buffers H
+ to form 
nondiffusible ammonium (NH4
+) and divalent basic phosphate (HPO4
-) is converted to the monovalent acid form (H2PO4
-) in H
+ presence. 
Intracellularly formed HCO3
- leaves the cell via Cl
- - HCO3
- exchange, facilitated by an anion exchanger (AE1). Cytoplasmic carbonic anhy-
drase II (CA II) is necessary to secret H
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pH below 5.5 following an NH4Cl load or a modified fu-
rosemide test [2,6,24]. Acquired distal RTA is often secon-
dary to autoimmune diseases, such as Sjogren’s syndrome 
[6,24]. Inherited distal RTA can be essentially of three types: 
autosomal dominant distal RTA (the commonest form) and 
autosomal recessive distal RTA with and without sen-
sorineural deafness [24]. In the complete forms of both 
dominant and recessive distal RTA bone disease is common 
(rickets or osteomalacia), as well as nephrocalcinosis (often) 
complicated by renal stone disease. The occurrence of renal 
stones is attributed to the combination of hypercalciuria, low 
urinary citrate excretion (due to systemic and intracellular 
acidosis) and high urine pH, all favouring calcium phosphate 
stone formation. Hypokalaemia, another characteristic fea-
ture, is less troublesome than in the acquired autoimmune 
form of distal RTA, but it can become symptomatic, espe-
cially if a thiazide diuretic is prescribed to reduce hypercal-
ciuria [24]. In recessive distal RTA, some patients suffer 
from sensorineural deafness, which can be late in onset [24]. 
  Conceptually, the proximal tubule is charged with the 
task of reclaiming filtered HCO3
- (~ 85% of the total) [13]. 
Failure of this process leads to reduction in systemic base, 
resulting in metabolic acidosis – proximal RTA [13]. Proxi-
mal RTA typically manifests as part of a generalized defect 
of proximal tubule function, namely the renal Fanconi’s syn-
drome (with glycosuria, low molecular weight proteinuria, 
urinary phosphate wasting, hypophosphataemia and hypouri-
caemia) [24]. Isolated proximal RTA occurs rarely and usu-
ally presents as growth retardation in childhood. Like distal 
RTA, it can be divided into three types: autosomal recessive 
proximal RTA with ocular abnormalities, autosomal reces-
sive proximal RTA with osteopetrosis and cerebral calcifica-
tion, and autosomal dominant proximal RTA [24]. Autoso-
mal recessive proximal RTA with ocular abnormalities is the 
commonest form of isolated and inherited proximal RTA, 
but even this is rare. Ocular abnormalities include band kera-
topathy, glaucoma and cataracts [24]. Short stature is usual; 
dental enamel defects, mental retardation, hypothyroidism, 
abnormal pancreatic function and basal ganglia calcification 
are also features [24,25]. In inherited CA II deficiency, iso-
lated proximal RTA presents with osteopetrosis (due to im-
paired osteoclast function), cerebral calcification and vari-
able mental retardation [26]. Although this form of inherited 
RTA is clinically more proximal in type, it can also present 
with a mixed proximal and distal phenotype, which reflects 
the presence of CA II in cells all along the renal tubule. 
  Type 3 RTA can be caused by recessive mutation in the 
CA2 gene on chromosome 8q22, which encodes CAII [4] or 
could involve direct interaction between CA II and the 
NBC1 [27] or Cl
–/ HCO3
– exchanger, SLC26A6 [4,28]. 
  The causes of type 4 RTA include various types of adre-
nal failure or pseudohypoaldosteronism type 1 (PHA1) due 
to defects in the mineralocorticoid receptor or the epithelial 
Na
+ channel, all characterized by salt loss and hypotension 
[4]. A similar picture may be seen in obstructive uropathy or 
drug induced interstitial nephritis [4]. Furthermore, a number 
of drugs may impair signalling in the renin–angiotensin-
aldosterone system and cause hyperkalemia and metabolic 
acidosis (e.g. potassium sparing diuretics, trimethoprim, cy-
clo-oxygenase inhibitors, angiotensin converting enzyme 
inhibitors) [4]. Lately, much interest has been given to a 
group of rare autosomal dominant diseases characterized by 
hyperkalaemia and acidosis and age-related hypertension [4]. 
In spite of hypervolaemia, aldosterone is not low and the 
disorders have been collectively termed pseudohypoaldos-
teronism type 2 (PHA2) [4]. 
INHERITED FORMS OF DISTAL RENAL TUBULAR 
ACIDOSIS 
  Inherited forms of distal RTA have three variants: auto-
somal dominant and autosomal recessive with or without 
deafness. Dominant disease typically presents more mildly in 
adolescence or adulthood, and recessive variant occurs in 
infancy/early childhood, where growth retardation is com-
mon [6]. In Table 1 we can see the chromosome mapping of 
distal RTA. 
Autosomal Dominant Distal RTA (Distal RTA Type 1a ) 
  Distal RTA occurs with the greatest frequency as an iso-
lated defect, often transmitted as an autosomal dominant trait 
[13]. In few reported families, the presence of the disorder in 
several generations suggests an autosomal dominant trans-
mission. Although clinical findings are not different from 
those observed in autosomal recessive or sporadic cases, in 
these patients the disease may be diagnosed later (in adoles-
cence or adulthood) [6] or manifest with milder symptoma-
tology.  
  Autosomal dominant distal RTA has been found to be 
associated in several kindred with mutations in the SLC4A1 
gene encoding the CI
-/HCO3
- exchanger, AE1 [15]. 
The Electroneutral Anion Exchanger (AE1) 
 The  Cl
-/HCO3
- anion exchanger, AE1, is a glycoprotein 
encoded by a gene (SLC4A1) present  on chromosome 17 
q21-22. SCL4A1 gene is a member of the SLC4 family com-
Table 1.  Chromosome Mapping of the Inherited Distal Renal Tubular Acidosis 
Inherited Distal RTA  Gene  Mapping  Protein Encoded 
Autosomal dominant  SLC4A1  Chromosome 17q21-q22  AE 1 exchanger 
Autosomal recessive 
(with deafness) 
ATP6V1B1  Chromosome 2q13  B1-subunit of H
+-ATPase 
Autosomal recessive 
(with preserved hearing) 
ATP6V0A4  Chromosome 7 q33-q34  a4 isoform subunit of  H
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prising 10 genes of which 8 encode bicarbonate ion trans-
porters [6,24,29]. AE1 is an integral membrane glycoprotein 
containing a long cytoplasmic N-terminus (~ 400 amino ac-
ids), 12–13 transmembrane domains (responsible for anion 
transport and dimerization), and a short cytoplasmic C-ter- 
minus (~ 35 amino acids) [30,31]. It is predominantly ex-
pressed in the erythrocytes (eAE1) and in the kidney (kAE1). 
  kAE1 is a truncated isoform of eAE1 with lacking of 65 
amino acids at the N-terminus owing to the use of differen-
tial transcription and translation start sites [32]. This extra 
NH2-terminal sequence confers additional roles for eAE1, 
including facilitation of red cell metabolism and mainte-
nance of erythrocyte structural stability via interaction with a 
glycolytic enzyme complex and cytoskeletal elements, re-
spectively [6]. kAE1 mediates an electroneutral exchange of 
chloride for bicarbonate at the basolateral membrane of acid 
secreting -intercalated cells of the distal nephron and col-
lecting duct [32,33]. This ion exchanger promotes the reab-
sorption of bicarbonate into the blood. Therefore, eAE1 de-
fect results in morphological changes of red blood cells 
(RBC) while kAE1 abnormality leads to distal RTA [32].  
  The physiological role of kAE1 in the regulation of distal 
nephron acid secretion is well established. In the acidifica-
tion process of the distal nephron, basolateral kAE1 mediates 
Na
+-independent, electroneutral Cl
-/HCO3
- exchange, allow-
ing HCO3
- to exit the -intercalated cells in concert with 
apical H
+ secretion via the vacuolar H
+-ATPase. 
AE1 Gene (SLC4A1) Mutations 
  Because of the expression of AE1 in two different cells 
(RBC and -intercalated distal tubular cells) with distinct 
functions, AE1 mutations show pleiotrophic effects resulting 
in two distinct and seemingly unrelated phenotypes: heredi-
tary spherocytosis (or other forms of erythrocyte abnormali-
ties) and distal RTA [31]. The largest group of mutations in 
human AE1 is associated with autosomal-dominant red cell 
dysmorphologies (hereditary spherocytosis – HS; and South-
east Asian ovalocytosis - SAO), where renal acid-base han-
dling is normal [6]. AE1 mutations also result in distal RTA, 
because the defect in AE1 affects anion Cl
-/HCO3
- exchanger 
at the basolateral membrane of the -intercalated cells in the 
distal nephron [31]. 
  SAO, a well-known erythrocyte disorder, is caused by a 
deletion of 27 bp in codons 400-408 in exon 11 (Ex11D27) 
of AE1 leading to a lack of 9 amino acids in the protein, 
which is inactive for anion transport. 
  How can be explained either the absence of red cell ab-
normalities in patients with distal RTA or the rarity of de-
fects in distal urinary acidification in patients with hemato-
logical disorders, when, in both circumstances, mutations in 
the same SLC4A1 gene are present? [15]. One exception is 
the homozygous AE1 mutant V488M (Band 3 Coimbra; 
GTG → ATG), which presents with severe anemia and renal 
acidification defect [34,35]. 
  The majority of AE1 mutations apparently cause only 
erythroid abnormalities without renal phenotype. Most cause 
autosomal dominant forms of HS and are not encountered in 
homozygous form, suggesting embryonic lethality [7]. 
  Dominant HS-associated AE1 mutations are generally 
not associated with distal RTA. Conversely, distal RTA-
associated AE1 mutations are also not commonly accompa-
nied with HS. Whereas HS missense mutations are distrib-
uted throughout AE1 cytoplasmic and transmembrane do-
mains, distal RTA mutations are restricted to AE1’s trans-
membrane domain. Although, the almost complete segrega-
tion between mutations associated with HS and with distal 
RTA is not fully understood [7]. 
  Autosomal dominant distal RTA was first associated with 
exon 14 nucleotide substitutions encoding missense muta-
tions in residue 589 (R589), in which the wild-type Arg is 
converted to His, Ser, or Cys [30,36]. A single base change 
alters the identical AE1 residue, R589, in eight of the ten 
reported kindred with dominant distal RTA, supporting the 
importance of this residue in the normal acidification proc-
ess. R589 lies at the intracellular border of the sixth trans-
membrane domain of the protein, adjacent to K590. These 
basic residues are conserved in all the known vertebrate an-
ion exchanger isoforms and are thought to form part of the 
site of intracellular anion binding. Arginine at this position is 
conserved in all vertebrate AE proteins, indicating its func-
tional importance [37]. 
  Three different mutations at this position (R589C, 
R589H, and R589S) were found in autosomal dominant dis-
tal RTA and two de novo R589H mutations have also been 
reported [30,32,36]. A high prevalence of AE1 R589 muta-
tions and the presence of at least two de novo mutations at 
this position suggest that codon 589 (CGC) is a “mutational 
hotspot” of AE1.  The mechanism of recurrent mutations 
probably involves methylation and deamination altering cy-
tosine (C) to thymine (T) in the CpG dinucleotides [37]. 
  Another missense mutation alters serine to phenylalanine 
at position 613 [36] within the adjacent transmembrane loop, 
evidencing the importance of this region of the protein. A 
further complex mutation results in a C-terminally truncated 
AE1 protein lacking the last 11 amino acids [29]. 
AE1 in Autosomal Recessive Distal RTA 
  Recent gene studies have shown that some of the AE1 
mutations are responsible for autosomal recessive distal 
RTA in several countries in Southeast Asia; these patients 
may be homozygous for the mutation or be compound het-
erozygotes of two different AE1 mutations, one of which is 
usually the SAO mutation [38,39]. The evaluation of the 
AE1 G701D mutation has provided the first explanation for 
how any distal RTA-associated AE1 mutation might cause 
the disease [40]. 
  Recessive distal RTA appears to result from the absence 
or a very marked deficiency of chloride-bicarbonate ex-
change activity in the basolateral membrane of the distal -
intercalated cell. In the case of the G701D mutation this oc-
curs because the mutant protein is totally dependent on the 
presence of glycophorin A (GPA) for its movement to the 
cell surface. GPA is a glycosylated protein that is associated 
with band 3 and has a single span across the erythrocyte 
membrane [38]. Expression in Xenopus  oocytes demon-
strated that GPA completely rescues the cell surface move-
ment of the G701D mutant band 3 to normal levels. This 
contrasts with normal band 3, which moves to the cell sur-56    Current Genomics, 2009, Vol. 10, No. 1  Pereira et al. 
face even in the absence of GPA, although GPA further en-
hances this movement. Red blood cells contain GPA but 
GPA is absent from the kidney, hence individuals homozy-
gous for the G701D mutation have normal levels of band 3 
in their red cells. It is proposed that, in homozygotes, the 
mutant G701D protein does not reach the basolateral mem-
brane of the -intercalated cell, but is turned over within the 
cell. In SAO/G701D compound heterozygotes, the SAO pro-
tein is presumed to reach the cell surface, but since it is inac-
tive in anion transport, it acts as if it were a band 3 null allele 
[38]. 
Autosomal Recessive Distal RTA with Deafness (Distal 
RTA Type 1b) 
  Recessive forms of distal RTA are related to mutations in 
the proton pump in -intercalated cells. The gene involved 
(ATP6V1B1) is located on chromosome 2q13, and encodes 
the B1-subunit of H
+-ATPase expressed apically on -inter- 
calated cells and also in the cochlea and endolymphatic sac 
[4,23]. 
  In the human cochlea, the H
+-ATPase appears to be re-
quired to maintain normal endolymph pH [6] given that the 
very high potassium concentration (approximately 150 
mmol/l) in this closed compartment is not normally accom-
panied by alkalinity of the endolymph [23]. ATP6V1B1 ex-
pression has also been observed in the male genital tract 
(with acidification requirement for sperm maturation) [29]. 
  Clinical findings, other than deafness, are identical to 
those present in patients with sporadic or autosomal reces-
sive distal RTA and normal hearing. There is great variation 
in the presentation of deafness, from birth to late childhood, 
it is progressive and does not respond alkali therapy [15]. 
The defects in B1 cause irreversible hair cell damage in hu-
man cochlea because of ambient electrolyte and pH abnor-
malities [29]. 
  Screening for mutations in this gene revealed fifteen dif-
ferent mutations in kindred. The majority of these mutations 
are likely to disrupt the structure, or abrogate the production, 
of the normal B1 subunit protein [29].  
The Human Vacuolar H
+-ATPase 
  The vacuolar-type proton ATPase (V- or H+-ATPase) is 
a multisubunit pump that is essential for normal acidification 
of intracellular vesicular structures. In each individual cell, 
H
+-ATPases may function in a variety of distinct but essen-
tial cellular processes. However, the mechanisms by which 
cells regulate the intracellular trafficking, final destination 
and activity of these proton pumps are unclear [41]. 
 The  H
+-ATPases are composed of two structural domains 
(membrane-bound V0 and cytoplasmic or peripheral V1) each 
formed of multiple subunits (a–e and A–H, respectively), 
which are responsible for ATP hydrolysis and proton trans-
port, respectively [6,23]. The mammalian H
+-ATPase is pre-
sumed to be similar to that of yeast (in which most of the 
structural studies have been performed) [23]. 
Autosomal Recessive Distal RTA with Preserved Hearing 
(Distal RTA Type 1c) 
  Individuals without hearing defects carry mutations at 
chromossome 7 q33-q34. The defective gene is ATP6V0A4, 
which encodes a kidney-specific a4 isoform subunit of H
+-
ATPase. The involvement of the a4 subunit in distal RTA 
shows that it must be essential for proper proton pump func-
tion in the kidney [29], but its role is not totally clear.  
  Site-directed mutagenesis studies of the yeast ‘a’ subunit 
ortholog Vph1p (the ‘a’ subunit in proton pumps localized to 
the yeast vacuole) have yielded some potential functions 
[42]. Some mutations showed that this subunit is important 
for the assembly of the proton pump, whereas other muta-
tions had greater effects on ATPase activity and proton 
transport. These studies suggest that the ‘a’ subunit is impor-
tant for both assembly and function of the pump [29,42]. 
INHERITED FORMS OF PROXIMAL RENAL TUBU-
LAR ACIDOSIS 
  Proximal RTA is caused by a reduction in bicarbonate 
reabsorption at the proximal tubules, resulting in low renal 
bicarbonate threshold. The most common proximal RTA in 
children is secondary to Fanconi Syndrome [2,43]. Rarely, 
RTA might also be consequence of an inherited or sporadic 
primary renal disorder.  
  The acquired proximal RTA follows exposure to drugs or 
some toxins and the etiopathogenesis is still unknown [2]. 
Among drugs that cause Fanconi Syndrome are gentamicin, 
cisplatin, ifosfamide, and sodium valproate [6]. In addition, 
some hematologic and autoimmune conditions, such as mye-
loma and Sjogren syndrome respectively, might also course 
with proximal RTA.  
  The proximal RTA resulting from Fanconi Syndrome is 
frequently part of a systemic syndrome. Among systemic 
disorders that result in RTA, the inheritance pattern is usu-
ally autosomal recessive. Some of these disorders are cysti-
nosis, tyrosinaemia, galactosaemia, Fanconi-Bickel syn-
drome and others (Table 2) [44]. These syndromes are a het-
erogeneous group of disorders, which genes are mapped in 
many chromosome regions.  
  The RTA non-related to Fanconi Syndrome is a rare dis-
order and might be sporadic, autosomal dominant or auto-
somal recessive. The autosomal recessive disorder is associ-
ated with ocular abnormalities, frequently coursing with 
mental retardation. Other clinical features are short stature, 
dental enamel defects, pancreatitis, and basal ganglia calcifi-
cation [45]. Loss-of-function mutations in the gene that codi-
fies the NBC-1, the SLC4A4 gene, were first identified in 
two Japanese subjects with proximal RTA associated with 
cataracts, glaucoma and band keratopathy [46]. NBC-1 is 
formed by 1,035 amino acids; it contains ten transmembrane 
domains and two cytoplasmic termini, and it is present in 
kidney, brain, eye, pancreas, heart, prostate, epididymis, 
stomach, and intestine. In the kidney, NBC-1 is expressed 
mainly at the basolateral membrane of the proximal tubule. 
At least two genes encode the NBC proteins. Mutations were 
identified in the human NBC-1 gene (SLC4A4) mapped at 
chromosome 4p21 [47,48].  
  Another interesting candidate gene for proximal RTA is 
the TASK gene. TASK2-potassium channel is a member of 
the tandem-pore domain potassium channel family and is 
located in pancreas, placenta, lung, small intestine, colon and 
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sorption in renal proximal tubules. Knockout mice for 
TASK2 gene course with metabolic acidosis associated with 
low bicarbonate levels [49]. However, no mutation in these 
genes was yet identified in individuals with proximal RTA.  
  Other inherited form of proximal RTA is the one result-
ing from mutations in the gene CA2 that encodes CAII. The 
carbonic anhydrases (CA) are member of a family of zinc 
metalloenzymes that catalyzes the hydration of CO2. The 
human CA2 maps to the chromosome region 8q22. In the 
kidney, the majority of CA activity is attributable to CA II, 
which is localized in proximal tubular cells and in -
intercalated cells of the cortical and outer medullary collect-
ing tubules [50]. Due to their localization, this RTA course 
with some proximal and distal components. In terms of clini-
cal aspects, this RTA present osteopetrosis, cerebral calcifi-
cation and different levels of mental retardation. 
  The autosomal dominant proximal RTA was originally 
described in a large Costa Rican family [51,52], consisting 
of nine individuals presenting growth retardation and osteo-
malacia. No gene was found to be associated with this clini-
cal presentation. Recently, another family with isolated 
proximal RTA inherited as an autosomal dominant disease 
was described [53]. The father and all four children had RTA 
with blood bicarbonate levels of 11-14 mEq/L and urine pH 
of 5.3-5.4 and all presented high bicarbonate fractional ex-
cretion. In terms of clinical aspects, they course only with 
short stature without other organ dysfunction. This family 
was investigated at the following genes: CA II, CA IV, CA 
XIV, NCB1, Na
+/H
+ exchanger (NHE-3), NHE-8, the regula-
tory proteins of NHE3, NHRF1 and NHRF2 and the Cl-
HCO
-
3 exchanger, SLC26A6. However, no mutation was 
found in any of the candidate genes studied. The study of 
these families might clarify other mechanisms involved in 
renal bicarbonate balance and a genome wide investigation 
of a pool of these families might result in interesting find-
ings.  
INHERITED FORMS OF RENAL TUBULAR ACIDO-
SIS TYPE 3 
  Type 3 RTA is a mixed type that exhibits both impaired 
proximal HCO3
- reabsorption and distal acidification. The 
condition is due to an inherited deficiency of CAII caused by 
a recessive mutation in the CA2 gene on chromosome 8q22, 
which encodes this widely expressed enzyme [4,6]. The ex-
pression of CAII is affected in bone, kidney (in both proxi-
mal and distal nephron segments, explaining the mixed aci-
dosis) and brain.  
  The mechanisms that underlie the clinical picture in type 
3 RTA, apart from much slower conversion of carbonic acid 
to and from bicarbonate, apparently also involve direct inter-
action between CA II and the kidney NBC1 [27] or Cl
–/ 
HCO3
– exchanger, SLC26A6  (a plasma membrane Cl
–/ 
HCO3
– exchanger with a suggested role in pancreatic HCO3
– 
secretion) [4,28]. Mutation of the identified CAII binding 
site reduced SLC26A6 activity, demonstrating the impor-
tance of this interaction [28]. 
  Patients with this deficiency exhibit osteopetrosis and 
cerebral calcification, as well as a mixed RTA with proximal 
and distal components [29]. This association of osteopetrosis 
and RTA is known as Guibaud-Vainsel syndrome or marble 
brain disease. Osteopetrosis is a condition of increased bone 
density, but also augmented bone fragility, leading to in-
creased fracture risk, plus intracerebral calcification, intellec-
tual impairment, growth failure, and facial dysmorphism. 
Excess bone growth leads to conductive deafness and can 
also cause blindness through compression of the optic nerve 
[6].  
  There is a considerable degree of heterogeneity, both in 
the predominance of proximal or distal acidosis and in the 
osteopetrotic phenotype [6]. In different kindred, mild or 
severe mental retardation has also been described. 
  Different mutations in CA2 gene have been described; for 
example, the common ‘Arabic’ mutation, consisting of loss 
of the splice donor site at the 5’ end of intron 2 [6,29].  
INHERITED FORMS OF HYPERKALEMIC RENAL 
TUBULAR ACIDOSIS 
  Type 4 RTA is a heterogeneous group of disorders asso-
ciated with hyperkalemia due to aldosterone deficiency or 
impairment in aldosterone molecular signaling. 
  Type 4 RTA might result from a PHA1. Some clinical 
aspects associated are hyponatremia, hyperkalemia, and ele-
vated plasma aldosterone and plasma renin activity. The in-
heritance might be autosomal dominant or autosomal reces-
sive [54]. The autosomal dominant is a frequent and mild 
kidney disorder without any other organ involvement [55]. 
Table 2.  Chromosome Mapping of the Inherited Fanconi Syndromes 
Inherited Fanconi Syndromes  Gene  Mapping 
Autosomal recessive  SLC4A4  Chromosome 4q21 
Dent´s syndrome  CLCN5  Chromosome Xp11.22 
Cystinosis  SLC3A1 
SLC7A9 
Chromosome 2p21 
Chromosome 19p13.1 
Tyrosinaemia type 1  FAH gene  Chromosome 15q23-q25 
Galactosemia  GALT gene  Chromosome 9p13 
Wilson´s disease  ATP7B gene  Chromosome 13q14.3-q21.1 58    Current Genomics, 2009, Vol. 10, No. 1  Pereira et al. 
This disorder seems to be associated to loss-of-function mu-
tations in the mineralocorticoid receptor gene, the MRL gene. 
MRL-knockout mice develop symptoms of pseudohypoal-
dosteronism. In humans clinical presentation varies from 
non-symptomatic to important neonatal sodium loss. The 
recessive inheritance is associated to sodium transport de-
fects in all aldosterone target tissues, not only kidney, but 
also colon, lungs, salivary and sweat glands. The recessive 
disorder is more severe and salt wasting is normally more 
pronounced. However, both types of inheritance might result 
in the same degree of natriuresis, hyperkalaemia and meta-
bolic acidosis.  
  Other inherited cause of type 4 RTA includes hyper- 
kalaemia associated with hypertension and low or normal 
levels of plasma aldosterone [56-58]. This syndrome is called 
pseudohypoaldosteronism type 2 (PHA2), or Gordon’s syn-
drome, which results in a renal aldosterone resistance inher-
ited as an autosomal dominant pattern [6]. Mutations in the 
gene of two isoforms of WNK serine-threonine kinases, 
WNK4 and WNK1  genes, were identified in patients with 
PHA2 [59]. WNKs are serine kinase proteins lacking a ly-
sine residue at the active site, being the WNK type 1 a regu-
latory protein from WNK 4.  WNK4 is found in the distal 
nephron and controls the sodium and chloride reuptake and 
inhibits potassium efflux [6]. 
CONCLUDING REMARKS 
  Renal tubular acidosis (RTA) is characterized by meta-
bolic acidosis due to renal impaired acid excretion. In this 
review, we summarized our current understanding of the 
hereditary diseases caused by mutations in genes encoding 
transporter or channel proteins operating along the renal tu-
bule. Further molecular studies of inherited tubular transport 
disorders may shed more light on the molecular pathophysi-
ology of these diseases and may significantly improve our 
understanding of the mechanisms underlying renal salt ho-
meostasis, urinary mineral excretion, and blood pressure 
regulation in health and disease. The identification of the 
molecular defects in inherited tubulopathies may provide a 
basis for future design of targeted therapeutic interventions 
and, possibly, strategies for gene therapy of these complex 
disorders. 
ABBREVIATIONS 
RTA  =  Renal Tubulat Acidosis 
NHE-3 = Na
+/H
+ exchanger 
CAIV  =  Carbonic anhydrase type IV  
CAII  =  Carbonic anhydrase type II 
NBC-1 = Na
+-dependent bicarbonate cotransporter  
AE1  =  Basolateral chloride-bicarbonate exchanger 
eAE1  =  Red cell anion exchanger 
kAE1  =  Kidney anion exchanger 
CA2 =  Carbonic  anhydrase  gene 
PHA1  =  Pseudohypoaldosteronism type 1 
PHA2  =  Pseudohypoaldosteronism type 2 
RBC  =  Red blood cells 
HS =  Hereditary  spherocytosis 
SAO =  Southeast  Asian  ovalocytosis 
GPA =  Glycophorin  A 
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